Patent ID: 8710083
Filing Date: 2014-04-29
Classification: A61P,C07D

Abstract:
1. A method of inhibiting immune cell activation comprising administering to the cell a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof, wherein: Y L one of X each Z is independently selected from the group consisting of a lower alkyl, a lower haloalkyl, a halo, a lower alkoxy, a lower alkyl sulfanyl, —S(O) R, for each occurrence is independently selected from —H or an alkyl; R R R R q, for each occurrence, is independently, an integer from 1 to 3; k is for each occurrence, is independently, an integer from 1 to 4; n is zero, 1 or 2; and p, for each occurrence, is independently 1 or 2.